Skip to main content

Ceftolozane and Tazobactam Injection Shortage

Last Updated: January 6, 2022
Status: Current

Reason for the Shortage
    • Merck had Zerbaxa on shortage due manufacturing issues related to sterility. They are the sole suppliers of ceftolozane and tazobactam injection.
Available Products
    • Zerbaxa intravenous injection, Merck, 1.5 gram, vial, 10 count, NDC 67919-0030-01

Estimated Resupply Dates

    • Merck has Zerbaxa 1.5 gram vials available.

Updated

Updated January 6, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created December 21, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.